Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Crosses Above Two Hundred Day Moving Average – Should You Sell?

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1.58 and traded as high as $2.38. Cumberland Pharmaceuticals shares last traded at $2.24, with a volume of 20,209 shares traded.

Wall Street Analysts Forecast Growth

Separately, StockNews.com assumed coverage on Cumberland Pharmaceuticals in a report on Tuesday, January 21st. They set a “hold” rating for the company.

Cumberland Pharmaceuticals Stock Down 5.1 %

The company has a quick ratio of 0.99, a current ratio of 1.13 and a debt-to-equity ratio of 0.41. The firm’s 50-day moving average price is $2.08 and its 200 day moving average price is $1.58. The firm has a market cap of $31.45 million, a P/E ratio of -2.91 and a beta of 0.13.

Cumberland Pharmaceuticals (NASDAQ:CPIX) last posted its earnings results on Thursday, November 7th. The specialty pharmaceutical company reported ($0.03) EPS for the quarter. Cumberland Pharmaceuticals had a negative net margin of 29.54% and a negative return on equity of 9.50%. The business had revenue of $9.09 million during the quarter.

Cumberland Pharmaceuticals Company Profile

Cumberland Pharmaceuticals Inc, a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.